Related Experiment Videos

Haemolytic uraemic syndrome

W L Robson1

  • 1Memorial Hospital of Rhode Island, Pawtucket, USA.

Paediatric Drugs
|August 18, 2000
PubMed

Insights

Haemolytic uraemic syndrome (HUS) affects 5-10% of children with E. coli O157:H7 infections, often causing acute kidney injury. Most children recover fully, but 5% may develop chronic kidney failure.

Area of Science:

  • Pediatric Nephrology
  • Infectious Diseases
  • Public Health

Background:

  • Diarrhoea-associated haemolytic uraemic syndrome (HUS) is a serious complication in children infected with Escherichia coli (E. coli) O157:H7.
  • It is a leading cause of acute kidney injury in pediatric populations.

Purpose of the Study:

  • To review the pathogenesis, clinical management, and long-term outcomes of childhood HUS.
  • To emphasize the importance of supportive care and public health measures in managing E. coli O157:H7 infections.

Main Methods:

  • Review of existing literature and 20-year follow-up studies on HUS.
  • Analysis of pathogenesis involving endothelial cell damage, white blood cell activation, and platelet interactions.

Main Results:

  • Approximately 5-10% of children with E. coli O157:H7 develop HUS.
  • Supportive care, including fluid and electrolyte balance, is crucial; dialysis is often required.
  • Long-term follow-up indicates 75% of children recover without significant sequelae, while 5% develop chronic renal failure.

Conclusions:

  • Effective management of HUS involves meticulous supportive care and public health interventions to prevent E. coli O157:H7 spread.
  • While most children achieve good recovery, a small percentage face long-term renal complications, necessitating ongoing monitoring.

Related Concept Videos